PRGO
Perrigo Company PLC
NYSE: PRGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$11.29
-1.91% today
Updated 2026-04-29
Market cap
$1.55B
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-10.12
Dividend yield
10.10%
52W range
$9 – $27
Volume
3.5M
Perrigo Company PLC (PRGO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.75B | $1.93B | $2.58B | $2.54B | $3.09B | $3.19B | $4.02B | $5.35B | $13.85B | $13.88B | $19.39B | $13.87B | $11.63B | $10.98B | $11.30B | $11.49B | $10.43B | $11.02B | $10.81B | $9.65B |
| Cash & equivalents | $19.02M | $30.30M | $318.60M | $316.13M | $97.57M | $310.10M | $602.49M | $779.90M | $800.00M | $799.50M | $417.80M | $622.30M | $678.70M | $551.10M | $354.30M | $631.50M | $1.86B | $600.70M | $751.30M | $558.80M |
| Current assets | $657.18M | $719.06M | $1.16B | $1.15B | $1.38B | $1.38B | $1.80B | $2.24B | $2.55B | $2.55B | $2.74B | $2.81B | $2.82B | $2.90B | $2.73B | $3.13B | $3.86B | $2.72B | $2.83B | $2.48B |
| Total liabilities | $1.11B | $1.17B | $1.64B | $1.61B | $2.00B | $1.66B | $2.17B | $3.02B | $5.16B | $5.19B | $9.36B | $7.91B | $5.46B | $5.32B | $5.50B | $5.83B | $5.27B | $6.18B | $6.04B | $5.33B |
| Current liabilities | $371.43M | $379.84M | $485.66M | $500.56M | $906.71M | $606.03M | $652.73M | $749.40M | $1.07B | $1.07B | $2.49B | $1.84B | $1.44B | $1.54B | $1.34B | $1.38B | $1.59B | $1.11B | $1.59B | $1.04B |
| Long-term debt | $621.72M | $650.76M | $895.10M | $875.00M | $935.00M | $875.00M | $1.33B | $1.93B | $3.09B | $5.25B | $4.97B | $5.22B | $3.27B | $3.05B | $3.37B | $3.53B | $2.92B | $4.07B | $3.63B | $3.58B |
| Shareholder equity | $640.74M | $754.47M | $933.72M | $921.92M | $1.09B | $1.53B | $1.85B | $2.33B | $8.69B | $8.69B | $10.04B | $5.96B | $6.17B | $5.67B | $5.80B | $5.66B | $5.15B | $4.84B | $4.77B | $4.32B |
| Retained earnings | $121.05M | $178.37M | $289.99M | $419.09M | $619.30M | $934.33M | $1.31B | $1.72B | $1.88B | $1.88B | $1.91B | $-2.10B | $-1.98B | $-1.84B | $-1.70B | $-1.86B | $-1.93B | $-2.07B | $-2.08B | $-2.25B |
| Accounts receivable | $282.05M | $328.09M | $334.74M | $374.25M | $478.22M | $573.60M | $651.90M | $935.10M | $935.00M | $935.10M | $1.19B | $1.18B | $1.13B | $1.07B | $1.24B | $593.50M | $652.90M | $697.10M | $739.60M | $642.30M |
| Inventory | $302.94M | $295.11M | $399.97M | $384.79M | $448.87M | $505.58M | $547.46M | $703.90M | $632.00M | $631.60M | $844.40M | $795.00M | $806.90M | $878.00M | $967.30M | $1.06B | $1.02B | $1.15B | $1.14B | $1.08B |
| Goodwill | $152.18M | $196.22M | $282.42M | $268.82M | $622.75M | $777.80M | $820.12M | $1.09B | $3.54B | $3.47B | $5.36B | $4.05B | $4.18B | $4.03B | $4.12B | $3.10B | $3.00B | $3.49B | $3.53B | $3.32B |